# GLP-1 Sellers That Publish a Dose Price Ladder, Counted | This GLP How many GLP-1 sellers publish a dose price ladder rather than an opening figure, counted across the whole roster, and why a printed ladder beats a promise that the price rises. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/research/who-publishes-a-glp1-dose-ladder Updated: 2026-10-28 Published: 2026-09-15 [← Research](https://thisglp.com/research) Formats # GLP-1 Sellers That Publish a Dose Price Ladder, Counted A minority of GLP-1 sellers print three or more rungs of a dose price ladder. Far fewer state that the price scales at all, and the two groups are not the same sellers. [This GLP Editorial Team](https://thisglp.com/about)September 20265 min readUpdated September 2026 Sellers publishing three or more rungs · 216 · The rest publish an opening figure and stop · rung 1 · rung 2 · rung 3 **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms). ## Key takeaways - 216 of 580 sellers — 37% — print three or more distinct figures on at least one line. - That is a different and rarer disclosure than saying the price rises, which only 44 sellers state at all. - A published ladder is the only version of that disclosure a buyer can plan a course against. - The test used here is mechanical: three or more distinct figures in one recorded pricing note. - Corpus: 580 sellers, read most recently October 2026. There are two quite different things a seller can do about dose pricing. It can tell you the price changes as the dose climbs. Or it can tell you what it changes to. Only the second is something a reader can budget against, and the gap between how often each happens is the subject of this page — one of several silences counted in [what sellers do not put on the page](https://thisglp.com/research/what-glp1-sellers-do-not-publish). ## How many actually print the numbers 216 sellers of 580 on this roster publish three or more distinct figures on at least one line — a ladder rather than a headline with a warning attached. That is 37% of the corpus. By contrast only 44 sellers state anywhere that their price scales with the dose, and 370 say nothing either way. The two numbers do not overlap as neatly as they should. A seller can publish a ladder without ever writing the sentence “the price rises with your dose”, and several do. The ladder is the better disclosure in that case, because it answers the question the sentence only raises. [Every seller printing a ladder](https://thisglp.com/tools/published-dose-ladders) is listed with its own note. A mechanical test, with a known blind spot A seller qualifies here by printing three or more distinct dollar figures in one recorded pricing note. That is deliberately dumb: it cannot be gamed by wording, and it credits nobody for merely saying the price changes. It will, however, miss a seller whose ladder lives in a table this desk recorded only the opening rung of. The count is a floor. ## Why a ladder beats a promise A flat-rate promise is worth more than a ladder if it holds, because it removes the question entirely. But a flat rate is a claim about the future and a ladder is a published fact about the present, and the second can be checked before ordering. [The disclosure scorecard](https://thisglp.com/tools/what-sellers-publish) marks both, and [the open-questions census](https://thisglp.com/tools/questions-they-leave-open) counts how often neither is offered. Counts are computed from this site’s own records at build time, most recently read October 2026. Nothing is modeled or taken from a third party. [Coby Health](https://thisglp.com/reviews/coby-health) makes this question tangible: its [semaglutide page](https://www.cobyhealth.com/treatments/weight-loss/semaglutide) separates dose options and purchase lengths. Read the dose and supply together before comparing figures. A table describes what is offered for sale; it does not tell you which dose a clinician will prescribe. ## Frequently asked What counts as publishing a ladder? Three or more distinct dollar figures in one recorded pricing note. It is a deliberately mechanical test: it cannot be gamed by wording, and it credits nobody for merely saying the price changes. Is a flat rate better than a ladder? If it holds, yes — it removes the question. But a flat rate is a claim about the future and a ladder is a published fact about the present, and only the second can be checked before ordering. Could a seller be missed by this count? Yes. A ladder living in a table where only the opening rung was recorded would not qualify, so the count is a floor rather than a census. ## Sources ## Where to get it ### Best GLP-1 injections Every injectable seller we can verify, with the price each one publishes and an honest read of what the trials measured. [Compare providers →](https://thisglp.com/best/compounded-semaglutide) ## More in Formats - [ Label-approved sites and semaglutide exposure · Abdomen · 2 in. from navel · similar · Thigh · under the skin · similar · Upper arm · under the skin · similar · Blood levels, not weight loss. No trial randomized people to a site. ### Where Should You Inject Ozempic? Abdomen, Thigh or Arm Gave the Same Exposure ](https://thisglp.com/research/where-should-you-inject-ozempic) - [ The labeled ladder — four weeks on every rung · 0.25 · wk 1–4 · 0.5 · wk 5–8 · 1 · wk 9–12 · 1.7 · wk 13–16 · 2.4 · wk 17+ · Milligrams weekly. No compounded product carries this label. ### Semaglutide Starting Dose: 0.25 mg, and What Compounding Changes ](https://thisglp.com/research/semaglutide-starting-dose) - [ Approved: weight management, US, April 2026 · Phase 3 in progress, not approved: · sleep apnea · hypertension · urinary incontinence · osteoarthritis pain · artery disease · A daily tablet, not a peptide, not an injection. ### Is There a GLP-1 Pill That Works? Two Tablets, Two Different Answers ](https://thisglp.com/research/does-the-glp1-pill-work-as-well-as-the-injection)